Clinical Trial Update: Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Goofice (Elobixibat) in patients with chronic constipation is ongoing or not yet updated in status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Goofice (Elobixibat)

Snippet

Sponsor: Synmosa Biopharma Corp. | Conditions: Constipation | Phase 3 | Status: UNKNOWN